QUANTERIX CORP (QTRX) Fundamental Analysis & Valuation

NASDAQ:QTRX • US74766Q1013

Current stock price

4.72 USD
-0.04 (-0.84%)
At close:
4.72 USD
0 (0%)
After Hours:

This QTRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. QTRX Profitability Analysis

1.1 Basic Checks

  • In the past year QTRX has reported negative net income.
  • In the past year QTRX has reported a negative cash flow from operations.
  • QTRX had negative earnings in each of the past 5 years.
  • In the past 5 years QTRX always reported negative operating cash flow.
QTRX Yearly Net Income VS EBIT VS OCF VS FCFQTRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M -100M

1.2 Ratios

  • QTRX's Return On Assets of -25.59% is on the low side compared to the rest of the industry. QTRX is outperformed by 71.93% of its industry peers.
  • QTRX has a Return On Equity of -36.23%. This is in the lower half of the industry: QTRX underperforms 64.91% of its industry peers.
Industry RankSector Rank
ROA -25.59%
ROE -36.23%
ROIC N/A
ROA(3y)-13.89%
ROA(5y)-15.09%
ROE(3y)-18.67%
ROE(5y)-19.21%
ROIC(3y)N/A
ROIC(5y)N/A
QTRX Yearly ROA, ROE, ROICQTRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200

1.3 Margins

  • Looking at the Gross Margin, with a value of 46.77%, QTRX is in line with its industry, outperforming 49.12% of the companies in the same industry.
  • QTRX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for QTRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-3.47%
QTRX Yearly Profit, Operating, Gross MarginsQTRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. QTRX Health Analysis

2.1 Basic Checks

  • QTRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for QTRX has been increased compared to 1 year ago.
  • Compared to 5 years ago, QTRX has more shares outstanding
  • There is no outstanding debt for QTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QTRX Yearly Shares OutstandingQTRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
QTRX Yearly Total Debt VS Total AssetsQTRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • QTRX has an Altman-Z score of -0.88. This is a bad value and indicates that QTRX is not financially healthy and even has some risk of bankruptcy.
  • QTRX's Altman-Z score of -0.88 is on the low side compared to the rest of the industry. QTRX is outperformed by 73.68% of its industry peers.
  • There is no outstanding debt for QTRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.88
ROIC/WACCN/A
WACC11.01%
QTRX Yearly LT Debt VS Equity VS FCFQTRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • QTRX has a Current Ratio of 2.84. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
  • QTRX has a Current ratio of 2.84. This is comparable to the rest of the industry: QTRX outperforms 52.63% of its industry peers.
  • QTRX has a Quick Ratio of 2.11. This indicates that QTRX is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of QTRX (2.11) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 2.11
QTRX Yearly Current Assets VS Current LiabilitesQTRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. QTRX Growth Analysis

3.1 Past

  • The earnings per share for QTRX have decreased strongly by -114.56% in the last year.
  • Looking at the last year, QTRX shows a very negative growth in Revenue. The Revenue has decreased by -18.05% in the last year.
  • QTRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.96% yearly.
EPS 1Y (TTM)-114.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.33%
Revenue 1Y (TTM)-18.05%
Revenue growth 3Y9.6%
Revenue growth 5Y9.96%
Sales Q2Q%24.72%

3.2 Future

  • Based on estimates for the next years, QTRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.79% on average per year.
  • The Revenue is expected to grow by 19.74% on average over the next years. This is quite good.
EPS Next Y39.08%
EPS Next 2Y23.01%
EPS Next 3Y15.79%
EPS Next 5YN/A
Revenue Next Year28.28%
Revenue Next 2Y20.84%
Revenue Next 3Y23.51%
Revenue Next 5Y19.74%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QTRX Yearly Revenue VS EstimatesQTRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M
QTRX Yearly EPS VS EstimatesQTRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. QTRX Valuation Analysis

4.1 Price/Earnings Ratio

  • QTRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year QTRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTRX Price Earnings VS Forward Price EarningsQTRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QTRX Per share dataQTRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as QTRX's earnings are expected to grow with 15.79% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.01%
EPS Next 3Y15.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QTRX Dividend Analysis

5.1 Amount

  • No dividends for QTRX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QTRX Fundamentals: All Metrics, Ratios and Statistics

QUANTERIX CORP

NASDAQ:QTRX (3/13/2026, 8:00:02 PM)

After market: 4.72 0 (0%)

4.72

-0.04 (-0.84%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)03-02
Earnings (Next)05-11
Inst Owners78.17%
Inst Owner Change1.23%
Ins Owners0.91%
Ins Owner Change1.91%
Market Cap220.47M
Revenue(TTM)138.90M
Net Income(TTM)-107.15M
Analysts48.89
Price Target7.65 (62.08%)
Short Float %9.48%
Short Ratio6.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.89%
Min EPS beat(2)-35.04%
Max EPS beat(2)-6.75%
EPS beat(4)1
Avg EPS beat(4)-22.83%
Min EPS beat(4)-55.23%
Max EPS beat(4)5.7%
EPS beat(8)4
Avg EPS beat(8)-8.44%
EPS beat(12)7
Avg EPS beat(12)7.71%
EPS beat(16)8
Avg EPS beat(16)-3.03%
Revenue beat(2)2
Avg Revenue beat(2)8.48%
Min Revenue beat(2)4.23%
Max Revenue beat(2)12.73%
Revenue beat(4)3
Avg Revenue beat(4)1.85%
Min Revenue beat(4)-14.99%
Max Revenue beat(4)12.73%
Revenue beat(8)6
Avg Revenue beat(8)1.21%
Revenue beat(12)10
Avg Revenue beat(12)4.33%
Revenue beat(16)12
Avg Revenue beat(16)2.26%
PT rev (1m)0%
PT rev (3m)15.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)2.58%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)0.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.59
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)-2.21
EYN/A
EPS(NY)-1.35
Fwd EYN/A
FCF(TTM)-1.71
FCFYN/A
OCF(TTM)-1.65
OCFYN/A
SpS2.97
BVpS6.33
TBVpS2.95
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.59%
ROE -36.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.77%
FCFM N/A
ROA(3y)-13.89%
ROA(5y)-15.09%
ROE(3y)-18.67%
ROE(5y)-19.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.78%
GM growth 5Y-3.47%
F-Score2
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.49%
Cap/Sales 1.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.84
Quick Ratio 2.11
Altman-Z -0.88
F-Score2
WACC11.01%
ROIC/WACCN/A
Cap/Depr(3y)43.27%
Cap/Depr(5y)125.98%
Cap/Sales(3y)2.49%
Cap/Sales(5y)6.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-63.33%
EPS Next Y39.08%
EPS Next 2Y23.01%
EPS Next 3Y15.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-18.05%
Revenue growth 3Y9.6%
Revenue growth 5Y9.96%
Sales Q2Q%24.72%
Revenue Next Year28.28%
Revenue Next 2Y20.84%
Revenue Next 3Y23.51%
Revenue Next 5Y19.74%
EBIT growth 1Y-43.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.28%
EBIT Next 3Y27.1%
EBIT Next 5YN/A
FCF growth 1Y-107.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.64%
OCF growth 3YN/A
OCF growth 5YN/A

QUANTERIX CORP / QTRX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for QUANTERIX CORP?

ChartMill assigns a fundamental rating of 3 / 10 to QTRX.


What is the valuation status for QTRX stock?

ChartMill assigns a valuation rating of 0 / 10 to QUANTERIX CORP (QTRX). This can be considered as Overvalued.


What is the profitability of QTRX stock?

QUANTERIX CORP (QTRX) has a profitability rating of 0 / 10.


Can you provide the financial health for QTRX stock?

The financial health rating of QUANTERIX CORP (QTRX) is 6 / 10.